Pasithea Therapeutics Ownership | Who Owns Pasithea Therapeutics?

Pasithea Therapeutics Ownership Summary

Pasithea Therapeutics is owned by 10.76% institutional investors, 1.49% insiders, and 87.74% retail investors. Janus henderson group is the largest institutional shareholder, holding 29.87% of KTTA shares. AdvisorShares Psychedelics ETF is the top mutual fund, with 3.09% of its assets in Pasithea Therapeutics shares.

KTTA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Pasithea Therapeutics	10.76%	1.49%	87.74%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Janus henderson group	2.10M	29.87%	$1.56M
Adage capital partners gp	2.10M	29.87%	$1.56M
Vivo capital	2.10M	29.87%	$1.56M
Ameriprise financial	1.35M	19.21%	$1.00M
Cable car capital	1.21M	17.16%	$894.89K
Stonepine capital management	831.30K	11.82%	$616.66K
Advisorshares investments	337.51K	4.80%	$250.36K
Persistent asset partners	290.56K	4.13%	$215.53K
Geode capital management	103.98K	1.48%	$77.14K
Renaissance	93.40K	1.33%	$69.28K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Cable car capital	1.21M	0.31%	$894.89K
Stonepine capital management	831.30K	0.25%	$616.66K
Vivo capital	2.10M	0.13%	$1.56M
Persistent asset partners	290.56K	0.08%	$215.53K
Advisorshares investments	337.51K	0.05%	$250.36K
Adage capital partners gp	2.10M	0.00%	$1.56M
Hurley capital	3.69K	0.00%	$2.74K
Janus henderson group	2.10M	0.00%	$1.56M
Xtx topco	33.75K	0.00%	$25.04K
Ameriprise financial	1.35M	0.00%	$1.00M

Top Buyers

Holder	Shares	% Assets	Change
Cable car capital	1.21M	0.31%	706.38K
Stonepine capital management	831.30K	0.25%	556.24K
Renaissance	93.40K	0.00%	93.40K
Geode capital management	103.98K	-	49.49K
Vanguard fiduciary trust	43.86K	-	43.86K

Top Sellers

Holder	Shares	% Assets	Change
Ameriprise financial	1.35M	0.00%	-579.23K
Acuta capital partners	-	-	-450.00K
Stempoint capital lp	-	-	-355.08K
Jane street group	-	-	-59.37K
Citadel advisors	-	-	-56.18K

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard fiduciary trust	43.86K	-	43.86K	$32.54K

Sold Out

Holder	Change
Magnolia private wealth	-33.33K
Citadel advisors	-56.18K
Jane street group	-59.37K
Stempoint capital lp	-355.08K
Acuta capital partners	-450.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	8	-68.00%	756,777	-94.14%	10	0.04%	4	-78.95%	-	-100.00%
Dec 31, 2025	1	-	33,333	-	-	-	1	-	-	-
Dec 31, 2023	8	-33.33%	248,808	-2.59%	-	103.48%	3	-57.14%	2	-33.33%
Sep 30, 2023	12	-	255,417	-32.44%	-	46.49%	7	40.00%	3	-
Jun 30, 2023	12	-	378,085	-1.83%	1	66.46%	5	25.00%	3	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
AdvisorShares Psychedelics ETF	771.81K	3.09%	11.78K
Vanguard Institutional Extnd Mkt Idx Tr	126.28K	0.51%	72.46K
Fidelity Extended Market Index	77.88K	0.31%	36.28K
Northern Trust Extended Eq Market Idx	19.37K	0.08%	17.70K
NT Ext Equity Mkt Index Fund - Lending	19.37K	0.08%	-
NT Ext Equity Mkt Idx Fd - L	19.37K	0.08%	-
Spartan Extended Market Index Pool F	13.51K	0.05%	13.37K
Fidelity Series Total Market Index	7.97K	0.03%	-
NT Ext Eq Mkt Indx Fd DC Lend T4	399.00	0.03%	399.00
NT Ext Eq Mkt Indx Fd DC Lend T3	399.00	0.03%	399.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 28, 2025	STEINMAN LAWRENCE	-	Buy	$100.00K
Nov 28, 2025	Marques Tiago	Chief Executive Officer	Buy	$25.00K
Nov 28, 2025	Dumesnil Simon	-	Buy	$25.00K
May 12, 2025	Marques Tiago	Chief Executive Officer	Sell	$792.00
Jun 02, 2023	STEINMAN LAWRENCE	-	Buy	$12.93K

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	-	-
2024 Q1	-	-
2023 Q2	1	-
2022 Q4	1	-
2022 Q3	13	-

KTTA Ownership FAQ

Who Owns Pasithea Therapeutics?

Pasithea Therapeutics shareholders are primarily institutional investors at 10.76%, followed by 1.49% insiders and 87.75% retail investors. The average institutional ownership in Pasithea Therapeutics's industry, Biotech Stocks , is 35.75%, which Pasithea Therapeutics falls below.

Who owns the most shares of Pasithea Therapeutics?

Pasithea Therapeutics’s largest shareholders are Janus henderson group (2.1M shares, 29.87%), Adage capital partners gp (2.1M shares, 29.87%), and Vivo capital (2.1M shares, 29.87%). Together, they hold 89.60% of Pasithea Therapeutics’s total shares outstanding.

Does Blackrock own Pasithea Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Pasithea Therapeutics.

Who is Pasithea Therapeutics’s biggest shareholder by percentage of total assets invested?

Cable car capital is Pasithea Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.31% of its assets in 1.21M Pasithea Therapeutics shares, valued at 894.89K$.

Who is the top mutual fund holder of Pasithea Therapeutics shares?

AdvisorShares Psychedelics ETF is the top mutual fund holder of Pasithea Therapeutics shares, with 3.09% of its total shares outstanding invested in 771.81K Pasithea Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools